214 related articles for article (PubMed ID: 25605296)
1. Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.
Shah AA; Hummers LK; Casciola-Rosen L; Visvanathan K; Rosen A; Wigley FM
Arthritis Rheumatol; 2015 Apr; 67(4):1053-61. PubMed ID: 25605296
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma.
Shah AA; Xu G; Rosen A; Hummers LK; Wigley FM; Elledge SJ; Casciola-Rosen L
Arthritis Rheumatol; 2017 Jun; 69(6):1306-1312. PubMed ID: 28217959
[TBL] [Abstract][Full Text] [Related]
3. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.
Shah AA; Rosen A; Hummers L; Wigley F; Casciola-Rosen L
Arthritis Rheum; 2010 Sep; 62(9):2787-95. PubMed ID: 20506513
[TBL] [Abstract][Full Text] [Related]
4. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
Lazzaroni MG; Cavazzana I; Colombo E; Dobrota R; Hernandez J; Hesselstrand R; Varju C; Nagy G; Smith V; Caramaschi P; Riccieri V; Hachulla E; Balbir-Gurman A; Chatelus E; Romanowska-Próchnicka K; Araújo AC; Distler O; Allanore Y; Airò P;
J Rheumatol; 2017 May; 44(5):639-647. PubMed ID: 28089973
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
[TBL] [Abstract][Full Text] [Related]
6. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
[TBL] [Abstract][Full Text] [Related]
7. Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
Moinzadeh P; Fonseca C; Hellmich M; Shah AA; Chighizola C; Denton CP; Ong VH
Arthritis Res Ther; 2014 Feb; 16(1):R53. PubMed ID: 24524733
[TBL] [Abstract][Full Text] [Related]
8. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
[TBL] [Abstract][Full Text] [Related]
9. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
[TBL] [Abstract][Full Text] [Related]
10. Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in Scleroderma.
Shah AA; Laiho M; Rosen A; Casciola-Rosen L
Arthritis Rheumatol; 2019 Sep; 71(9):1571-1579. PubMed ID: 30888702
[TBL] [Abstract][Full Text] [Related]
11. Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.
Cavazzana I; Ceribelli A; Airo' P; Zingarelli S; Tincani A; Franceschini F
Autoimmun Rev; 2009 Jun; 8(7):580-4. PubMed ID: 19393210
[TBL] [Abstract][Full Text] [Related]
12. Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease Course.
Kim JS; Woods A; Gutierrez-Alamillo L; Laffoon M; Wigley FM; Hummers LK; Rosen A; Zeger S; Domsic RT; Casciola-Rosen L; Shah AA
Arthritis Rheumatol; 2024 Jan; 76(1):68-77. PubMed ID: 37488962
[TBL] [Abstract][Full Text] [Related]
13. Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.
Saigusa R; Asano Y; Nakamura K; Miura S; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Noda S; Aozasa N; Akamata K; Sumida H; Miyazaki M; Tamaki Z; Yanaba K; Kuwano Y; Sato S
J Dermatol; 2015 May; 42(5):524-7. PubMed ID: 25720827
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
[TBL] [Abstract][Full Text] [Related]
15. Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis.
Ceribelli A; Cavazzana I; Airò P; Franceschini F
J Rheumatol; 2010 Jul; 37(7):1544. PubMed ID: 20595295
[No Abstract] [Full Text] [Related]
16. Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis.
Wuttge DM; Carlsen AL; Teku G; Steen SO; Wildt M; Vihinen M; Hesselstrand R; Heegaard NH
Rheumatology (Oxford); 2015 Nov; 54(11):2100-7. PubMed ID: 26163687
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
[TBL] [Abstract][Full Text] [Related]
18. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
[TBL] [Abstract][Full Text] [Related]
19. Anti-RNA polymerase III antibodies are associated with scleroderma renal crisis in a French cohort.
Emilie S; Goulvestre C; Bérezné A; Pagnoux C; Guillevin L; Mouthon L
Scand J Rheumatol; 2011; 40(5):404-6. PubMed ID: 21623662
[No Abstract] [Full Text] [Related]
20. Inclusion body myositis in a patient with RNA polymerase III antibody-positive systemic sclerosis.
Vemulapalli S; Sharer LR; Hsu VM
J Rheumatol; 2015 Apr; 42(4):730-2. PubMed ID: 25834244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
